Stay updated on Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    A notice about NIH website terminology appears above the 403 error page. The site revision identifier changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T22:41:07.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision indicator changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T22:45:39.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a Home link. This replaces the study record content and removes the detailed trial sections such as eligibility criteria and listed locations.
    Difference
    19%
    Check dated 2026-09-23T00:42:48.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision metadata was updated from v3.6.6 to v3.7.0, indicating a newer version of the study entry. This update appears to be a backend or documentation change rather than a modification to the study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-09-15T23:47:41.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.5 to v3.6.6, signaling a new version of the ClinicalTrials.gov record.
    Difference
    0.1%
    Check dated 2026-09-01T19:43:39.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page's Revision tag was updated from v3.6.4 to v3.6.5, indicating a newer version of the page. This is a metadata update and does not modify study content or details.
    Difference
    0.0%
    Check dated 2026-08-11T14:46:44.000Z thumbnail image

Stay in the know with updates to Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+RT+Bevacizumab in Recurrent Methylated Glioblastoma Clinical Trial page.